PSMD1 and COVID-19: Our data clearly demonstrated that the CHO-expressed full length SARS-CoV-2 S1-Fc fusion protein can solicit very strong neutralizing activities against SARS-CoV-2 in a pretty short time period and could be a good candidate for COVID-19 vaccine development.